In the present study, HCC-SR cells were insensitive to sorafenib-induced ferroptosis when exposed to sorafenib, while depletion of FASN resulted in the accumulation of lipid peroxides, which activated ferroptosis and restored sensitivity to sorafenib. The gene discussed is FASN; the disease is hepatocellular carcinoma.